ACM
CLB icon

Astenbeck Capital Management’s Core Laboratories CLB Stock Holding History

Astenbeck Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-91,631
Closed -$17.5M – 2
2013
Q4 		$17.5M Sell
91,631
-13,885
-13% -$2.58M 9.58% 4
2013
Q3 		$17.9M Sell
105,516
-1,961
-2% -$304K 9.42% 6
2013
Q2 		$16.3M Buy
+107,477
New +$15.2M 9.16% 6

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Astenbeck Capital Management's CLB Position: Q1 2014 in Review

Astenbeck Capital Management sold out of Core Laboratories (CLB) in Q1 2014, closing a stake of 91,631 shares — an estimated $17.5M sold.

Astenbeck Capital Management first reported a position in CLB in Q2 2013 and held it in 3 quarters. The position peaked at $17.9M in Q3 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q1 2014.

  • Astenbeck Capital Management reported no remaining Core Laboratories position as of Q1 2014 after selling out during the quarter.
  • Astenbeck Capital Management sold 91,631 Core Laboratories shares in Q1 2014, an estimated $17.5M.
  • Astenbeck Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 3 quarters.
  • Astenbeck Capital Management's Core Laboratories position peaked at $17.9M in Q3 2013.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2014.

Based on Astenbeck Capital Management's 13F filing for Q1 2014, filed 15 May 2014.